Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Miluna Acquisition Corp 10-Q: Q3 2026 Trust at $71.3M

Miluna Acquisition Corp filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results and balance sheet data for the blank-check company listed on NASDAQ:MMTX.

Aakashdeep | 09 November 2026

W. R. Berkley Holds 8.1% Stake in Kochav Defense

W. R. Berkley Corporation and its subsidiary Berkley Insurance Company filed Amendment No. 3 to Schedule 13G on November 9, 2026, disclosing beneficial ownership of Class A ordinary shares in Kochav Defense Acquisition Corp. as of September 30, 2026.

Vinay Lochav | 09 November 2026

Select Water Solutions Files Q3 2026 Report With 136M Shares

Select Water Solutions, Inc. filed its quarterly report on Form 10-Q with the Securities and Exchange Commission for the period ended September 30, 2026, disclosing share counts and key company details as of November 5, 2026.

Aakashdeep | 09 November 2026

Kochav Defense SPAC Revises Trust Account Contribution Terms

Kochav Defense Acquisition Corp. filed a Form 8-K on November 9, 2026, disclosing updated trust account contribution terms ahead of its extraordinary general meeting scheduled for November 13, 2026.

Shwetambri Chauhan | 09 November 2026

Abeona Therapeutics Files Q3 2026 Report With 57.1M Shares

Abeona Therapeutics Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the fiscal quarter ended September 30, 2026.

Shwetambri Chauhan | 09 November 2026

Kochav Defense SPAC Files 10-Q for September 30, 2026

Kochav Defense Acquisition Corp. filed a quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the period ended September 30, 2026.

Anjali Anand | 09 November 2026

Xenon Pharma Registers 300,000 More Inducement Plan Shares

Xenon Pharmaceuticals Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 9, 2026, registering an additional 300,000 common shares under its Amended and Restated 2025 Inducement Equity Incentive Plan.

Aditi Sarkar | 09 November 2026

Tecnoglass Revises Q3 2026 Net Income Down $6M on Tax Fix

Tecnoglass Holdings Inc. filed a Form 8-K/A (Amendment No. 1) on November 9, 2026, correcting its previously reported third-quarter and nine-month 2026 financial results to reflect a valuation allowance on a deferred tax asset related to treasury stock accounting.

Nitish Kishor | 09 November 2026

Tecnoglass Q3 2026: Revenue Rises to $310.6M, Net Income Falls

Tecnoglass Holdings Inc. (NYSE:TGLS) filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 9, 2026, reporting total operating revenues of $310.6 million for the third quarter and net income of $16.7 million.

Nitish Kishor | 09 November 2026

Xenon Pharmaceuticals Posts Q3 2026 Results, Shares Top 98M

Xenon Pharmaceuticals Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing balance sheet data showing total assets of $1,199,875 thousand and an accumulated deficit of $1,568,853 thousand.

Anjali Anand | 09 November 2026
Support

Hi! How can we help you today?

Loading…